Philip Noraini, William Timothy, John Daisy Vanitha
Universiti Malaysia Sabah, Biotechnology Research Institute, Jalan UMS, 88400 Kota Kinabalu, Sabah, Malaysia.
Malays J Pathol. 2015 Apr;37(1):1-9.
Tuberculosis (TB) which is caused by Mycobacterium tuberculosis infects primarily the lungs but it also affects other parts of the body. Tuberculous meningitis (TBM) is the most severe form of TB and has the highest mortality and morbidity rate compared to other forms of TB. It is common in young children and HIV-infected patients, but is also seen in adults. Despite anti-tuberculosis treatment, TBM is still a major cause of death and neurological sequelae as treatment given to the patients is often delayed. Early diagnosis is challenging due to the non-specific symptoms of TBM and the low number of tubercle bacilli in cerebrospinal fluid (CSF). Until now, there is no established diagnostic method that can rapidly detect M. tuberculosis in TBM patients with high sensitivity and specificity. The emergence of drug resistant M. tuberculosis strains further complicates the diagnosis and treatment regimen of TBM. This review summarizes challenges of the currently used diagnostic methods and the potential future use of molecular diagnostic methods for TBM.
由结核分枝杆菌引起的结核病主要感染肺部,但也会影响身体的其他部位。结核性脑膜炎(TBM)是结核病最严重的形式,与其他形式的结核病相比,其死亡率和发病率最高。它在幼儿和艾滋病毒感染患者中很常见,但在成人中也有发现。尽管进行了抗结核治疗,但由于对患者的治疗往往延迟,TBM仍然是死亡和神经后遗症的主要原因。由于TBM的症状不具特异性且脑脊液(CSF)中结核杆菌数量较少,早期诊断具有挑战性。到目前为止,还没有一种既定的诊断方法能够以高灵敏度和特异性快速检测TBM患者中的结核分枝杆菌。耐多药结核分枝杆菌菌株的出现使TBM的诊断和治疗方案更加复杂。本综述总结了目前使用的诊断方法面临的挑战以及分子诊断方法未来在TBM中的潜在应用。